LXXGF - LexaGene Holdings Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

LexaGene Holdings Inc.

500 Cummings Center
Suite 4550
Beverly, MA 01915
United States

IndustryDiagnostics & Research
Full Time Employees21

Key Executives

NameTitlePayExercisedYear Born
Dr. John F. ReganFounder, Chairman & CEO299.65kN/AN/A
Mr. Darrel M. RebeckPres & Director257.1kN/AN/A
Mr. Jeffrey MitchellCFO, Treasurer & Corp. Sec.176.82kN/AN/A
Mr. Allan FabbroVP of Corp. Devel.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in clinical and life sciences industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. Its technology aims to transform the way organizations prevent and diagnose disease in various markets, such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and others. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

Corporate Governance

LexaGene Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.